A biotechnology and medical device company that announced plans to acquire BNB.
AI-generated insights about Windtree Therapeutics, Inc. from various financial sources
Announced plans to buy up to $700 million worth of BNB, contributing to the corporate treasury narrative driving BNB's price momentum.
Announced plans to buy up to $700 million worth of BNB, contributing to the corporate treasury narrative driving BNB's price momentum.